Summary & Overview
CPT 80323: Alkaloid Drug Level Analysis
CPT code 80323 covers laboratory testing to identify and quantify alkaloid drugs in a patient specimen when no more specific CPT code applies. This specialized toxicology test matters nationally because it supports clinical decision-making in cases of suspected poisoning, overdose, therapeutic monitoring of alkaloid-based therapies, and forensic investigations. The code is relevant to hospitals, outpatient laboratories, and reference labs that perform advanced analytical testing.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, and the types of services it represents. The publication also summarizes common billing modifiers and payer considerations, national reimbursement context, and how this code fits into laboratory service lines and toxicology workflows. Policy updates, payer coverage patterns, and benchmarking information are discussed where available. Data not available in the input is noted when applicable.
Billing Code Overview
CPT code 80323 describes a laboratory analysis in which a lab analyst identifies and evaluates the level of alkaloid drugs in a patient specimen that are not specified elsewhere in CPT by a different code from the class of alkaloids. This service is a specialized toxicology/drug-testing laboratory procedure used to detect and quantify alkaloid compounds in biological samples.
-
Service type: Laboratory toxicology analysis of unspecified alkaloid drugs
-
Typical site of service: Clinical laboratory or hospital laboratory setting
Clinical & Coding Specifications
Clinical Context
A 32-year-old emergency department patient presents with altered mental status and suspected recreational drug ingestion after being found confused and agitated at a nightclub. The treating clinician orders comprehensive toxicology testing to identify an alkaloid class drug not otherwise specified by standard panels. A blood specimen is collected, labeled, and sent to the clinical laboratory. The laboratory analyst performs a targeted quantitative assay to identify and evaluate the level of an alkaloid drug (for example, a novel or uncommon plant-derived alkaloid) using methods such as liquid chromatography–mass spectrometry (LC-MS/MS). The lab documents specimen accessioning, analytic method, results with units and reference range, and any confirmatory testing. Results are reported to the ordering clinician for acute management decisions (antidote administration, observation, or admission) and are appended to the patient’s medical record. Billing is submitted under 80323 for the laboratory identification and evaluation of the alkaloid drug level.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing only the professional interpretation by the laboratory pathologist or clinical chemist separate from technical testing |